Open access
Aug 2026
Metabolomics-Defined Subtypes of Prediabetes and Risk of Cardiovascular-Kidney-Metabolic Outcomes
Whether data-driven clustering based on metabolomic biomarkers could define distinct prediabetes subtypes with differential type 2 diabetes, cardiovascular disease, and chronic kidney disease risk is examined and metabolomics-based subtypes may improve risk stratification and support precision prevention strategies.
Fei Chen, Yang Zhang, Weihao Wang et al.
· Diabetes · 0 citations